Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients
Loading...
Date
2003
Journal Title
Journal ISSN
Volume Title
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Abstract
Saccharomyces boulardii is widely used as a probiotic compound. Clinical data suggest that this agent is safe and effective. We report two cases of fungemia caused by S. cerevisiae occurring in immunosuppressed patients treated orally with S. boulardii. Molecular typing confirmed clonality in isolate strains from patients and the S. boulardii capsule. Physicians caring for immunosuppressed patients must be aware of this potential serious complication of probiotic use.
Description
Keywords
Saccharomyces cerevisiae fungemia, Saccharomyces boulardii, immunocompromised patients, ANTIBIOTIC-ASSOCIATED DIARRHEA, IDENTIFICATION, PREVENTION, CHILDREN